$139.99 -$0.51 (-0.4%)

04:00 PM EST on 12/10/19

Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 4 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Current Price $139.99 Mkt Cap $369.8B
Open $140.80 P/E Ratio 26.38
Prev. Close $140.50 Div. (Yield) $3.75 (2.7%)
Daily Range $139.91 - $140.97 Volume 1,674,766
52-Wk Range $125.00 - $144.98 Avg. Daily Vol. 7,507,724

Caps

How do you think NYSE:JNJ will perform against the market?

Add Stock to CAPS Watchlist

All Players

13,580 Outperform
509 Underperform
 

All-Star Players

2,951 Outperform
66 Underperform
 

Wall Street

9 Outperform
1 Underperform
 

Top NYSE:JNJ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFbelle (63.88)
Submitted July 02, 2014

A stock which I feel should be a staple in every dividend/value investor portfolio. The quality of this company has stood the test of time and they continue to remain relevant and successful via strategies that strengthen it's ongoing competitive… More

acegdl007 (84.78)
Submitted January 20, 2011

J&J is not a company that has experienced significant growth (in terms of stock price) over the past few years. It has mainly sustained its self on it's brand name recognition that has been significantly tarnished in 2010 due to several recalls.… More

Recent Community Commentary

Read the most recent pitches from players about JNJ.

Recs

0
Member Avatar nolledge (52.00) Submitted: 10/10/2019 12:36:37 AM : Underperform Start Price: $130.10 NYSE:JNJ Score: -0.21

Rationale: Johnson & Johnson has a lot of risk from various law suits, and they tend to compound (bad evidence from one increases risk from another). I also think the device/pharma industries have had a great couple decades and broadly have risk of underperforming if they lose their ability to pass on exorbitant product prices to a price-insenstive 3rd party payer.

Risk: they trade at a reasonable market value, so they just have to continue to perform to beat my expectation. But I just need them to take bigger hits than expected, relative to the market.

Recs

0
Member Avatar TMFCheesehead (94.74) Submitted: 5/20/2019 10:28:55 AM : Outperform Start Price: $135.84 NYSE:JNJ Score: -6.67

Don't think it'll be a market-thumper, but a solid choice

Recs

0
Member Avatar CellBlock9 (90.56) Submitted: 12/18/2018 9:14:44 PM : Outperform Start Price: $126.32 NYSE:JNJ Score: -11.76

spyg

Leaderboard

Find the members with the highest scoring picks in JNJ.

Score Leader

PassDaRice2

PassDaRice2 (77.41) Score: +133.07

The Score Leader is the player with the highest score across all their picks in JNJ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
tarfu773 88.60 7/30/2007 Outperform 5Y $41.31 +239.66% +123.59% +116.07 1 Comment
UWxBadger 93.95 7/30/2007 Outperform 5Y $41.33 +239.48% +123.42% +116.06 0 Comment
diediedieno 40.60 7/27/2007 Outperform 5Y $41.33 +239.43% +123.37% +116.06 0 Comment
bullear1 63.72 7/24/2007 Outperform 3Y $42.32 +231.49% +115.46% +116.03 0 Comment
jbarnes1217 94.11 7/24/2007 Outperform 3Y $42.32 +231.49% +115.46% +116.03 0 Comment
paladin65 < 20 7/24/2007 Outperform 1Y $42.32 +231.49% +115.46% +116.03 1 Comment
cando123 24.04 7/24/2007 Outperform 5Y $42.32 +231.49% +115.46% +116.03 0 Comment
GreedyMo 94.17 7/24/2007 9/30/2012 Outperform 5Y $42.32 +231.49% +115.46% +116.03 0 Comment
fartalope < 20 7/24/2007 Outperform 5Y $42.32 +231.49% +115.46% +116.03 1 Comment
kaibigan 20.43 7/24/2007 Outperform NS $42.32 +231.49% +115.46% +116.03 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for JNJ.